S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Drugs from Isis' Lipid Franchise Highlighted at European Society of Cardiology Congress 2014|
|Isis Pharmaceuticals Earns $1 Million from GSK for Advancing ISIS-TTR Rx|
|Isis Pharmaceuticals Earns $1.5 Million From GSK for the Advancement of ISIS-GSK4 Rx|
|Isis Pharmaceuticals Earns $18 Million From GSK for Advancing ISIS-TTR Rx|
|Isis Reports Financial Results and Highlights for Second Quarter 2014 (2014/8/4)|
|Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy|
|Isis Pharmaceuticals Initiates Phase 2 Study of ISIS-APO(a) Rx in Patients with High Lp(a)|
|Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-APOCIII Rx in Patients with FCS|
|Isis Pharmaceuticals Earns $2M from the Advancement of ISIS-SMN Rx in Children with Spinal Muscular Atrophy|
|Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call|
Click above to view more mutual fund data and stats for isis - Isis Pharmaceuticals.